Molly B El-Alam

5PUBLICATIONS
40CO-AUTHORS
Probability theoryEpidemiological methodsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 01, 2026
Interpreting Treatment Effects Using Posterior Probabilities: A Bayesian Reanalysis of 230 Phase III Oncology Trials.

|Dec 23, 2025
Linking Microbiome Diversity and Immune Profiles in Ethiopian Patients With Cervical Cancer.

Kyoko Yoshida-Court, Brhanu Teka, Tatiana Cisneros Napravnik

|Jan 27, 2025
Survival-Inferred Fragility of Statistical Significance in Phase III Oncology Trials.

Alexander D Sherry, Yufei Liu, Pavlos Msaouel

|Aug 12, 2024
Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial Misinterpretation.

Timothy A Lin, Zachary R McCaw, Alex Koong

|Feb 23, 2021
Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation.

Travis T Sims, Molly B El Alam, Tatiana V Karpinets

Pageof 1

Frequent Collaborators

3 joint publications

Tomer Meirson

3 joint publications

Ethan B Ludmir

3 joint publications

Alexander D Sherry

3 joint publications

Timothy A Lin